PTC Therapeutics, Inc. (PTCT)
NASDAQ · Healthcare
PTC Therapeutics, Inc. Revenue 2011–2025
PTC Therapeutics, Inc. annual/quarterly revenue history and growth rate from 2011 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- PTC Therapeutics, Inc. revenue for the quarter ending March 31, 2026 was 272.6 M, a 76.83% decrease year-over-year.
- PTC Therapeutics, Inc. revenue for the twelve months ending March 31, 2026 was 1.8 B, a 132.67% increase year-over-year.
- PTC Therapeutics, Inc. annual revenue for 2025 was 1.7 B, a 114.51% increase from 2024.
- PTC Therapeutics, Inc. annual revenue for 2024 was 806.8 M, a 13.97% decrease from 2023.
- PTC Therapeutics, Inc. annual revenue for 2023 was 937.8 M, a 34.20% increase from 2022.
- PTC Therapeutics, Inc. annual revenue for 2022 was 698.8 M.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Ptc Therapeutics Inc. Market Cap — FAQ
Ptc Therapeutics Inc. (PTCT) market cap over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PTCT's market cap history?
The chart and table above show Ptc Therapeutics Inc.'s market cap by year and by quarter, including the growth rate.